FAKTOR-OPTIONSSCHEIN - SMITH & NEPHEW | Market Closed - Börse Stuttgart 08:23:29 23/05/2024 pm IST | ||
| 10.09 EUR | +9.32% |
|
| Current month | -9.24% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
Latest news about SMITH & NEPHEW PLC
More news
| Date | Price | Change |
|---|---|---|
| 23/24/23 | 10.09 | +9.32% |
| 22/24/22 | 9.23 | -1.28% |
| 21/24/21 | 9.35 | +6.25% |
| 20/24/20 | 8.8 | -2.11% |
| 17/24/17 | 8.99 | -0.33% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 08:23 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Morgan Stanley |
| WKN | MG2XM9 |
| ISIN | DE000MG2XM93 |
| Date issued | 24/04/2024 |
| Strike | 1,353 p |
| Maturity | Unlimited |
| Parity | 0.43 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.85 € |
|---|---|
| Lowest since issue | 8.77 € |
| Spread | 0.03 € |
| Spread % | 0.30% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.49
USD
Average target price
16.31
USD
Spread / Average Target
+30.61%
- Stock Market
- Certificates
- Certificat
